Summary
The distribution of cancer antigen 125 (CA 125) has been investigated in normal tissues and carcinomas of the Müllerian duct by immunohistochemical methods using the monoclonal antibody OC 125. Detection of CA 125 was most intense in cryostat sections and decreased in formalin fixed and paraffin embedded tissues according to the duration of fixation. Enzymatic digestion with neuraminidase or alkaline hydrolysis abolished specific staining suggesting the antigen is a sialylsaccharide bound to protein by alkali-labile linkage. Immunohistochemical staining demonstrated the presence of CA 125 in all normal glandular epithelia of the endocervix, endometrium and fallopian tube in different distribution patterns. In normal endometrium the cellular distribution pattern was related to the menstrual cycle. In endocervical, endometrial and tubal adenocarcinomas CA 125 was found in 73% of cases. In glandular structures the antigen was concentrated at the luminal surface of the tumour cells, in solid tumour areas it was spread throughout the cytoplasm or concentrated in large cytoplasmic vacuoles. The expression of CA 125 was considerably lower in solid tumour areas. These data show that CA 125 is not a true “tumour marker”, but a product of female genital mucosae and of their cancerous derivates provided their synthesizing ability is not lost in the course of pathologic differentiation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Babic R, Füger Th, Gössner W, Schröck R, Hafter R, Graeff H (1986) Immunhistochemischer Nachweis von CA 125, TPA, Fibrinogen und Fibronektin in Ovarialkarzinomen vor und nach Chemotherapie. In: Greten H, Klapdor R (Hrsg) Klinische Relevanz neuer monoklonaler Antikörper. Thieme, Stuttgart, pp 338–348
Bast RC, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC (1981) Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 68:1331–1337
Bast RC, Klug TL, St. John E, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parker L, Zurawski VR, Knapp RC (1983) A radioimmunoassay using a monoklonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 309:883–887
Crombach G, Zippel HH, Würz H (1985) Erfahrungen mit CA 125, einem Tumormarker für maligne epitheliale Ovarialtumoren. Geburtsh Frauenheilkd 45:205–212
Crombach G, Scharl A, Würz H (1989) Occurrence of CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and fallopian tube. II: Immunoradiometric determination in secretions, tissue extracts and serum. Arch Gynecol Obstet 244:113–122
De Bruijn HWA, van Beeck Calkoen-Carpay T, Jager S, Duk MJ, Aalders JG, Fleuren GJ (1986) The tumor marker CA 125 is a common constituent of normal cervical mucus. Am J Obstet Gynecol 154:1088–1091
De Bruijn HWA, Aalders JG, Kauer FM, Duk MJ, van Beeck Calkoen-Carpay T, Fleuren GJ (1987) The biodistribution of CA 125 in the female genital tract. In: Klapdor R (ed) New tumour markers and their monoclonal antibodies. Thieme, Stuttgart, pp 334–339
Dietel M, Arps H, Klapdor R (1985) Morphologisch-klinische Korrelation der Tumormarker CA 19-9, CA 125 und CEA bei Pankreaskarzinomen. In: Greten H, Klapdor R (Hrsg) Neue tumorassoziierte Antigene. Thieme, Stuttgart, pp 78–85
Duk JM, Aalders JG, Fleuren GJ, de Bruijn HWA (1987) CA 125: a useful marker in endometrial carcinoma. Am J Obstet Gynecol 155:1097–1102
Ferenczy A (1982) Carcinoma and other malignant tumors of the cervix. In: Blaustein A (ed) Pathology of the female genital tract. Springer, New York Berlin Heidelberg, pp 184–222
Hanisch F-G, Uhlenbruck G, Dienst C, Stottrop M, Hippauf E (1985) CA 125 and CA 19-9: two cancer-associated sialylsaccharide antigens on a mucus glycoprotein from human milk. Eur J Biochem 149:323–330
Kabawat SE, Bast RC, Bhan RK, Welch WR, Knapp RC, Colvin RB (1983) Tissue distribution of a coelomic-epithelium related antigen recognized by the monoclonal antibody OC 125. Int J Gynecol Pathol 2:275–285
Kurman RJ, Norris HJ (1982) Endometrial neoplasia: hyperplasia and carcinoma. In: Blaustein A (ed) Pathology of the female genital tract. Springer, New York Berlin Heidelberg, pp 311–351
Makovitzky J (1986) The distribution and localization of the monoclonal antibody defined antigen 19-9 (CA 19-9) in chronic pancreatitis and pancreatic carcinoma. An immunohistochemical study. Virchows Arch [B] 51:535–544
Niloff JM, Klug TL, Schaetzl E, Zurawski VR, Knapp RC, Bast RC (1984) Elevation of serum CA 125 in carcinomas of the fallopian tube, endometrium and endocervix. Am J Obstet Gynecol 148:1057–1058
O'Brien TJ, Hardin JW, Bannon GA, Norris JS, Quirk JG (1986) CA 125 antigen in human amniotic fluid and fetal membranes. Am J Obstet Gynecol 155:50–55
Schilthuis MS, Aalders JG, Bouma J, Kooi H, Fleuren GJ, Willemse PHB, de Bruijn HWA (1987) Serum CA 125 levels in epithelial ovarian cancer: relation with findings at second look operations and their role in the detection of tumour recurrence. Br J Obstet Gynecol 94:202–207
Wheeler JE (1982) Pathology of the fallopian tube. In: Blaustein A (ed) Pathology of the female genital tract. Springer, New York Berlin Heidelberg, pp 393–415
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scharl, A., Crombach, G., Vierbuchen, M. et al. CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and fallopian tube. Arch Gynecol Obstet 244, 103–112 (1989). https://doi.org/10.1007/BF00931381
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00931381